A Dispensing Clinical Trial of Comfilcon A Extended Range Multifocal Lenses

July 20, 2020 updated by: Coopervision, Inc.
The aim of this study is to validate the clinical of comfilcon A extended range high add center near (CN) multifocal lenses in existing contact lens wearers against the current comfilcon A high add multifocal lenses.

Study Overview

Detailed Description

This study is a 13-subject, randomized, prospective, single site, daily wear, single-masked (to the subject), bilateral, 4-day cross-over, dispensing study comparing the comfilcon A extended range multifocal test lens against the comfilcon A multifocal control lens.

Study Type

Interventional

Enrollment (Actual)

14

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Indiana
      • Bloomington, Indiana, United States, 47405
        • CORL, Indiana University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

50 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

A person is eligible for inclusion in the study if he/she:

  • Has had a self-reported oculo-visual examination in the last two years
  • Is 50 years of age or greater and has full legal capacity to volunteer
  • Is able to read and understand the informed consent
  • Is willing and able to follow instructions and maintain the appointment schedule
  • Has a spherical distance contact lens prescription between -1.00 and -5.00D (Diopters) (inclusive)
  • Near Add Power requirement of +2.25D or greater
  • Has spectacle cylinder 0.75 D in both eyes
  • Has normal binocularity (no amblyopia, no strabismus, no habitually uncorrected anisometropia ≥ 2.00D)
  • Has monocular best-corrected distance visual acuity of 20/30 or better in each eye
  • Has clear corneas and no active ocular disease
  • Has not worn gas permeable contact lenses for 1 month prior to the study

Exclusion Criteria:

A person will be excluded from the study if he/she:

  • Has never worn contact lenses before
  • Has any systemic disease affecting ocular health
  • Is using any systemic or topical medications that will affect ocular health
  • Has any ocular pathology or abnormality that would affect the wearing of contact lenses
  • Is aphakic (i.e. missing their natural lens inside their eye)
  • Has uncorrected anisometropia (i.e. difference in the prescription between the eyes) of ≥2.00 D
  • Has undergone corneal refractive surgery
  • Is participating in any other type of eye related clinical or research study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: comfilcon A Extended Range test lens
Subjects will be randomized to wear either the test or control pair of lens, then cross over to the alternate pair.
contact lens
contact lens
Active Comparator: comfilcon A control lens
Subjects will be randomized to wear either the test or control pair of lens, then cross over to the alternate pair.
contact lens
contact lens

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Visual Acuity
Time Frame: 4 days
Visual acuity was measured at distance, intermediate and near conditions for test and control lens was assessed by LogMAR.
4 days
Visual Performance
Time Frame: 4 days
Subjective assessment of visual performance for test and control lens is assessed on a scale 0-100, 0=extremely poor vision all of the time and cannot function, 100= excellent vision all of the time).
4 days

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Subjective Preference for Comfort
Time Frame: 4 days
Subjective preference for comfort for test and control contact lenses.
4 days
Subjective Preference for Intermediate Vision
Time Frame: 4 days
Subjective preference for intermediate vision for test and control contact lenses.
4 days
Subjective Preference for Distance Vision
Time Frame: 4 days
Subjective preference for distance vision for test and control contact lenses.
4 days
Average Daily Wearing Time
Time Frame: 4 days
Average daily wearing time for test and control lens is assessed in hours.
4 days
Subjective Ratings for Comfort
Time Frame: Baseline
Subjective ratings for comfort was assessed for test and control lens on a Scale 0-100, 0=cannot be worn, causes pain, 100=cannot be felt ever).
Baseline
Subjective Ratings for Comfort
Time Frame: 4 days
Subjective ratings for comfort was assessed for test and control lens on a Scale 0-100, 0=cannot be worn, causes pain, 100=cannot be felt ever).
4 days
Subjective Ratings for Dryness
Time Frame: Baseline
Subjective ratings for dryness was assessed for test and control lens on a scale 0-100, 0=cannot be worn, extremely dry, 100=no dryness experienced at any time).
Baseline
Subjective Ratings for Dryness
Time Frame: 4 days
Subjective ratings for dryness was assessed for test and control lens on a scale 0-100, 0=cannot be worn, extremely dry, 100=no dryness experienced at any time).
4 days
Lens Handling
Time Frame: 4 Days
Subjective ratings for handling (ease of insertion and removal) was assessed for test and control lens on a scale 0-100, 0=very difficult to handle, 100=easy to handle).
4 Days
Lens Fit
Time Frame: 4 days
Lens fit acceptance (general fit characteristics) is assessed for test and control lens on a 0-4 grading system in 0.25 steps where 0 represented very poor fit.
4 days
Bulbar Hyperemia
Time Frame: 4 days
Bulbar hyperemia was assessed on a scale of 0-4 and was used in 0.50 steps, with 0 indicating no hyperemia and 4 indicating severe hyperemia.
4 days
Limbal Hyperemia
Time Frame: 4 days
Limbal hyperemia was assessed on a scale of 0-4 and was used in 0.50 steps, with 0 indicating no hyperemia and 4 indicating severe hyperemia.
4 days
Subjective Satisfaction
Time Frame: 4 days
Subjective satisfaction for test and control lens was assessed on a scale 0-100, 0=extremely dissatisfied, 100=very satisfied)
4 days
Subjective Preference for Near Vision
Time Frame: 4 days
Subjective preference for near vision for test and control contact lenses. comfort, vision, handling, satisfaction.
4 days
Subjective Preference for Overall Vision
Time Frame: 4 days
Subjective preference for overall vision for test and control contact lenses.
4 days
Subjective Overall Lens Preference
Time Frame: 4 days
Subjective overall lens preference for test and control contact lenses.
4 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Pete S Kollbaum, O.D., Indiana University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

March 1, 2016

Primary Completion (Actual)

May 1, 2016

Study Completion (Actual)

August 1, 2016

Study Registration Dates

First Submitted

March 21, 2016

First Submitted That Met QC Criteria

March 21, 2016

First Posted (Estimate)

March 25, 2016

Study Record Updates

Last Update Posted (Actual)

July 30, 2020

Last Update Submitted That Met QC Criteria

July 20, 2020

Last Verified

July 1, 2020

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • CV-16-02

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated device product

Yes

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Presbyopia

Clinical Trials on comfilcon A Extended Range test lens

3
Subscribe